Therapy Areas: Vaccines
Cuba's Abdala COVID-19 vaccine shows 92.28% efficacy in late clinical trials
22 June 2021 -

Cuba has stated that its three-shot Abdala COVID-19 vaccine had proved 92.28% effective in last-stage clinical trials, Reuters news agency reported on Tuesday.

This announcement on 21 June 2021 came just days after the Cuban government said another domestic vaccine, Soberana II, had proved 62% effective against COVID-19.



Related Headlines